← All companies

DCOY

Decoy Therapeutics Inc.

DCOY Nasdaq Pharmaceutical Preparations EDGAR ↗

$4.34

+0.23 +5.60%

Key statistics

from XBRL data in SEC filings

Market cap

$2.31M

Revenue (TTM)

$0.00

Net income (TTM)

$12.0M

EPS (TTM)

$106.79

P/E ratio

0.0

Dividend yield

—

Free cash flow

-$5.40M

Cash

$7.82M

Total assets

$8.42M

Gross margin

—

52-week range

$3.51 – $113.40

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Shareholder vote results Jul 15, 2026 8-K Entered a material agreement; Unregistered sale of equity; Regulation FD disclosure Jun 29, 2026 8-K Item 5.08; Other events May 19, 2026 10-Q Quarter ended 2026-03-31 May 8, 2026 10-K/A Fiscal year ended 2025-12-31 Apr 30, 2026 8-K Other events Apr 2, 2026 10-K Fiscal year ended 2025-12-31 Mar 31, 2026 8-K Modified rights of security holders; Amended charter or bylaws; Other events Mar 5, 2026 8-K Shareholder vote results Feb 25, 2026 8-K Amended charter or bylaws; Other events Jan 8, 2026 8-K Delisting notice or listing-rule failure Jan 2, 2026 8-K Shareholder vote results Jan 2, 2026 8-K Shareholder vote results; Regulation FD disclosure Dec 19, 2025 8-K Director or officer change Nov 19, 2025 8-K Regulation FD disclosure Nov 17, 2025 10-Q Quarter ended 2025-09-30 Nov 14, 2025 8-K Entered a material agreement; Completed an acquisition or disposition; Unregistered sale of equity; Modified rights of security holders; Director or officer change; Amended charter or bylaws; Other events Nov 13, 2025 8-K Director or officer change Oct 21, 2025 8-K Other events Oct 14, 2025 8-K Other events Oct 6, 2025 8-K Entered a material agreement; Modified rights of security holders Sep 18, 2025 8-K Other events Sep 9, 2025 8-K Other events Aug 27, 2025 8-K Other events Aug 26, 2025 8-K/A 8-K Aug 26, 2025 8-K Other events Aug 22, 2025 8-K Director or officer change Aug 18, 2025 8-K Modified rights of security holders; Amended charter or bylaws; Other events Aug 15, 2025 10-Q Quarter ended 2025-06-30 Aug 12, 2025 8-K Results of operations (earnings release); Unregistered sale of equity Jul 31, 2025 8-K Entered a material agreement; Modified rights of security holders Jul 29, 2025 8-K Other events Jul 28, 2025 8-K Entered a material agreement; Modified rights of security holders Jul 21, 2025 8-K Other events Jul 14, 2025 8-K Shareholder vote results Jul 8, 2025 8-K Other events Jun 16, 2025 8-K Entered a material agreement Jun 11, 2025 10-Q Quarter ended 2025-03-31 May 14, 2025 8-K Delisting notice or listing-rule failure Apr 25, 2025 8-K Entered a material agreement; Delisting notice or listing-rule failure Mar 28, 2025